Peter Hodder

5.3k citations

135 papers · 4.0k indexed · h-index 36

Impact in

Cell Biology top 2%
- Endoplasmic Reticulum Stress and Disease
Molecular Biology top 5%
- Receptor Mechanisms and Signaling
- Ubiquitin and proteasome pathways
- Sphingolipid Metabolism and Signaling

Papers in ⓘ

Molecular Biology 91
- Receptor Mechanisms and Signaling 30
- Sphingolipid Metabolism and Signaling 9
- Protein Kinase Regulation and GTPase Signaling 7
- Protein Degradation and Inhibitors 7
Aging 2

Co-authors: Peter Chase (52 shared papers)Timothy Spicer (47 shared papers)Franck Madoux (32 shared papers)Hugh Rosen (37 shared papers)S. Adrian Saldanha (15 shared papers)Dmitriy Minond (12 shared papers)Steven J Brown (26 shared papers)William Roush (17 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (12 papers)SLAS DISCOVERY (12 papers)Assay and Drug Development Technologies (7 papers)ACS Chemical Biology (6 papers)Journal of Medicinal Chemistry (5 papers)
Partner nations: United States Australia New Zealand

In The Last Decade

Peter Hodder

132 papers receiving 4.0k citations

Peers

Countries citing papers authored by Peter Hodder

Since Specialization

Citations

This map shows the geographic impact of Peter Hodder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hodder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hodder more than expected).

Fields of papers citing papers by Peter Hodder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hodder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hodder. The network helps show where Peter Hodder may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter Hodder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter Hodder Line = papers co-authored together Peter Hodder links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 135 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways Proceedings of the National Academy of Sciences ·Tsui‐Fen Chou, Steve Brown, Dmitriy Minond, Brian E. Nordin, Kelin Li, Amanda C. Jones, Peter Chase, Patrick Porubsky, Brian M. Stoltz, Frank J. Schoenen, Matthew P. Patricelli, Peter Hodder, Hugh Rosen, Raymond J. Deshaies	2011	259
2	Small-molecule proteostasis regulators for protein conformational diseases Nature Chemical Biology ·Barbara Calamini, Maria Catarina Silva, Franck Madoux, Darren M. Hutt, Shilpi Khanna, Monica A. Chalfant, S. Adrian Saldanha, Peter Hodder, Bradley D. Tait, Dan Garza, William E. Balch, Richard I. Morimoto	2011	180
3	Small molecule proteostasis regulators that reprogram the ER to reduce extracellular protein aggregation eLife ·Lars Plate, Christina B. Cooley, John J. Chen, Ryan J Paxman, Ciara M Gallagher, Franck Madoux, Joseph C. Genereux, Wesley Dobbs, Dan Garza, Timothy Spicer, Louis Scampavia, Steven J Brown, Hugh Rosen, Evan T. Powers, Peter Walter, Peter Hodder, R. Luke Wiseman, Jeffery W. Kelly	2016	173
4	Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease Journal of Medicinal Chemistry ·Jon Jacobs, Valerie Grum‐Tokars, Ya Zhou, Mark Turlington, S. Adrian Saldanha, Peter Chase, Aimee L. Eggler, Eric S. Dawson, Yahira M. Báez-Santos, Sakshi Tomar, Anna M. Mielech, Susan C. Baker, Craig W. Lindsley, Peter Hodder, Andrew D. Mesecar, Shaun R. Stauffer	2012	155
5	Bufalin Is a Potent Small-Molecule Inhibitor of the Steroid Receptor Coactivators SRC-3 and SRC-1 Cancer Research ·Ying Wang, David M. Lonard, Yang Yu, Dar‐Chone Chow, Timothy Palzkill, Jin Wang, Ruogu Qi, Alexander J. Matzuk, Xianzhou Song, Franck Madoux, Peter Hodder, Peter Chase, Patrick R. Griffin, Suoling Zhou, Lan Liao, Jianming Xu, Bert W. O’Malley	2014	144
6	Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors Journal of Biological Chemistry ·Lei Zhou, Kimberly M. Lovell, Kevin J. Frankowski, Stephen R. Slauson, Angela M. Phillips, John M. Streicher, Edward L. Stahl, Cullen L. Schmid, Peter Hodder, Franck Madoux, Michael D. Cameron, Thomas E. Prisinzano, Jeffrey Aubé, Laura Bohn	2013	122
7	Confirming Target Engagement for Reversible Inhibitors in Vivo by Kinetically Tuned Activity-Based Probes Journal of the American Chemical Society ·Alexander Adibekian, Brent R. Martin, Jae Won Chang, Ku‐Lung Hsu, Katsunori Tsuboi, Daniel A. Bachovchin, Anna E Speers, Steven J Brown, Timothy Spicer, Virneliz Fernández-Vega, Jill Ferguson, Peter Hodder, Hugh Rosen, Benjamin F. Cravatt	2012	117
8	Identification of a μ-δ opioid receptor heteromer-biased agonist with antinociceptive activity Proceedings of the National Academy of Sciences ·Ivone Gomes, Wakako Fujita, Achla Gupta, S. Adrian Saldanha, Ana Negri, Christine E. Pinello, Christina Eberhart, Edward Roberts, Marta Filizola, Peter Hodder, Lakshmi A. Devi	2013	111
9	Small Molecule Activators of TRPML3 Chemistry & Biology ·Christian Grimm, Simone Jörs, S. Adrian Saldanha, Alexander G. Obukhov, Bifeng Pan, Kazuo Oshima, Math P. Cuajungco, Peter Chase, Peter Hodder, Stefan Heller	2010	104
10	Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding Bioorganic & Medicinal Chemistry Letters ·Mark Turlington, Aspen Chun, Sakshi Tomar, Aimee L. Eggler, Valerie Grum‐Tokars, Jon Jacobs, J. Scott Daniels, Eric S. Dawson, Adrian Saldanha, Peter Chase, Yahira M. Báez-Santos, Craig W. Lindsley, Peter Hodder, Andrew D. Mesecar, Shaun R. Stauffer	2013	100
11	Identification of Histone Deacetylase Inhibitors with Benzoylhydrazide Scaffold that Selectively Inhibit Class I Histone Deacetylases Chemistry & Biology ·Yunfei Wang, Ryan L. Stowe, Christie E. Pinello, Guimei Tian, Franck Madoux, Dawei Li, Lisa Zhao, Jian‐Liang Li, Yuren Wang, Yuan Wang, Haiching Ma, Peter Hodder, William Roush, Daiqing Liao	2015	90
12	Endogenous and Synthetic ABHD5 Ligands Regulate ABHD5-Perilipin Interactions and Lipolysis in Fat and Muscle Cell Metabolism ·Matthew A. Sanders, Franck Madoux, Ljiljana Mladenovic, Huamei Zhang, Xiangqun Ye, Michelle Angrish, Emilio P. Mottillo, Joseph A. Caruso, Geoff T. Halvorsen, William Roush, Peter Chase, Peter Hodder, James G. Granneman	2015	90
13	Academic cross-fertilization by public screening yields a remarkable class of protein phosphatase methylesterase-1 inhibitors Proceedings of the National Academy of Sciences ·Daniel A. Bachovchin, Justin T. Mohr, Anna E Speers, Chu Wang, Jacob M. Berlin, Timothy Spicer, Virneliz Fernández-Vega, Peter Chase, Peter Hodder, Stephan C. Schürer, Daniel K. Nomura, Hugh Rosen, Gregory C. Fu, Benjamin F. Cravatt	2011	87
14	Small-Molecule Inhibitors of Acetyltransferase p300 Identified by High-Throughput Screening Are Potent Anticancer Agents Molecular Cancer Therapeutics ·Heng Yang, Christie E. Pinello, Jian Luo, Dawei Li, Yunfei Wang, Lisa Zhao, Stephan C. Jahn, S. Adrian Saldanha, Jamie L. Planck, Kyla Geary, Haiching Ma, Brian K. Law, William Roush, Peter Hodder, Daiqing Liao	2013	82
15	Potent and Selective Inhibitors of Glutathione S-Transferase Omega 1 That Impair Cancer Drug Resistance Journal of the American Chemical Society ·Katsunori Tsuboi, Daniel A. Bachovchin, Anna E Speers, Timothy Spicer, Virneliz Fernández-Vega, Peter Hodder, Hugh Rosen, Benjamin F. Cravatt	2011	80
16	NH-1,2,3-Triazole Inhibitors of the VIM-2 Metallo-β-Lactamase ACS Medicinal Chemistry Letters ·Timo Weide, S. Adrian Saldanha, Dmitriy Minond, Timothy Spicer, Joseph R. Fotsing, Michael Spaargaren, Jean‐Marie Frère, Carine Bebrone, K. Barry Sharpless, Peter Hodder, Valery V. Fokin	2010	74
17	Unique drug screening approach for prion diseases identifies tacrolimus and astemizole as antiprion agents Proceedings of the National Academy of Sciences ·Yervand E Karapetyan, Gian Franco Sferrazza, Minghai Zhou, Gregory Ottenberg, Timothy Spicer, Peter Chase, Mohammad Fallahi, Peter Hodder, Charles Weissmann, Corinne Ida Lasmézas	2013	73
18	Inhibition of Adrenocortical Carcinoma Cell Proliferation by Steroidogenic Factor-1 Inverse Agonists The Journal of Clinical Endocrinology & Metabolism ·Mabrouka Doghman, Julie Cazareth, Dominique Douguet, Franck Madoux, Peter Hodder, Enzo Lalli	2009	70
19	Development of an intact cell reporter gene β-lactamase assay for G protein-coupled receptors for high-throughput screening Analytical Biochemistry ·Priya Kunapuli, Richard W. Ransom, Kathy Murphy, D. J. PETTIBONE, Julie Kerby, Sarah Grimwood, Paul Zuck, Peter Hodder, Raul Lacson, Ira Hoffman, James Inglese, Berta Strulovici	2003	69
20	A Rational Utilization of High-Throughput Screening Affords Selective, Orally Bioavailable 1-Benzyl-3-carboxyazetidine Sphingosine-1-phosphate-1 Receptor Agonists Journal of Medicinal Chemistry ·Jeffrey J. Hale, Christopher L. Lynch, William Neway, Sander G. Mills, Richard Hajdu, Carol Keohane, Mark Rosenbach, James A. Milligan, Gan-Ju Shei, Stephen A. Parent, Gary Chrebet, James D. Bergstrom, Deborah Card, Marc Ferrer, Peter Hodder, Berta Strulovici, Hugh Rosen, Suzanne Mandala	2004	65

About Peter Hodder

Peter Hodder is a scholar working on Molecular Biology, Aging, Molecular Medicine, Cellular and Molecular Neuroscience and Immunology and Allergy, having authored 135 papers that have together received 4.0k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (30 papers), Peptidase Inhibition and Analysis (18 papers), Neuropeptides and Animal Physiology (10 papers), Sphingolipid Metabolism and Signaling (9 papers), Estrogen and related hormone effects (7 papers), Neuroscience and Neuropharmacology Research (7 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Protein Degradation and Inhibitors (7 papers). The work is most often cited by research in Cell Biology (596 citations), Molecular Biology (2.5k citations), Physiology (148 citations), Aging (55 citations) and Cellular and Molecular Neuroscience (529 citations). Peter Hodder has collaborated with scholars based in United States, Australia and New Zealand. Frequent co-authors include Peter Chase, Timothy Spicer, Franck Madoux, Hugh Rosen, S. Adrian Saldanha, Dmitriy Minond, Steven J Brown, William Roush, Virneliz Fernández-Vega and Benjamin F. Cravatt. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, SLAS DISCOVERY, Assay and Drug Development Technologies, ACS Chemical Biology and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact